Alnylam Pharmaceuticals
ALNY
#649
Rank
NZ$68.81 B
Marketcap
NZ$515.43
Share price
-0.61%
Change (1 day)
-4.15%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company